Medical treatment of benign prostatic hyperplasia.
Schmidt
J D
JD
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000726:Androgen Antagonists / Q000627:therapeutic use; D000736:Androstenes / Q000627:therapeutic use; D001378:Azasteroids / Q000627:therapeutic use; D002064:Buserelin / Q000031:analogs & derivatives / Q000627:therapeutic use; D018120:Finasteride; D017273:Goserelin; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000726:Androgen Antagonists; D000736:Androstenes; D001378:Azasteroids; D017273:Goserelin; D018120:Finasteride; D016729:Leuprolide; D002064:Buserelin